Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy

European Journal of Pharmacology

Volumn 477, Issue 1, 2003, Pages 73-80

  Bedekovic, Vlado ^a   Mise, Stjepan ^a   Anic, Tomislav ^a   Staresinic, Mario ^a   Gjurasin, Miroslav ^a   Kopljar, Mario ^a   Kalogjera, Livije ^a   Drvis, Petar ^a   Boban Blagaic, Alenka ^a   Batelja, Lovorka ^a   Seiwerth, Sven ^a   Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atropine; Cysteamine; Cytoprotection; Duodenal ulcer; Gastrectomy; Gastric pentadecapeptide BPC 157 (PLD 116); Omeprazole; Ranitidine; Salivary gland; Sialoadenectomy

Indexed keywords

ANTIULCER AGENT; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MERCAPTAMINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DUODENUM ULCER; FEMALE; GASTRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVARY GLAND; SIALADENECTOMY; SURGICAL TECHNIQUE; ULCEROGENESIS;

ANIMALS; ANTI-ULCER AGENTS; ATROPINE; CYSTEAMINE; DUODENAL ULCER; FEMALE; GASTRECTOMY; OMEPRAZOLE; PEPTIDE FRAGMENTS; PROTEINS; RANITIDINE; RATS; RATS, WISTAR; SUBMANDIBULAR GLAND;

EID: 12144289586     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.013     Document Type: Article

References (39)

1. Evangelista S., Renzi D., Guzzi P., Maggi C.A. Interactions between sialoadenectomy and capsaicin-sensitive afferent fibers on gastric acid secretion in rats. Life Sci. 48:1991;PL37-PL41.
2. Hui W.M., Chen B.W., Kung A.W., Cho C.H., Luk C.T., Lam S.K. Effect of epidermal growth factor on gastric blood flow in rats: possible role in mucosal protection. Gastroenterology. 104:1993;1605-1610.
3. Inaloz H.S., Ketani M.A., Inaloz S.S., Yilmaz F., Ketani S. The effects of sialoadenectomy and flutamide on skin development. Clin. Exp. Obstet. Gynecol. 27:2000;231-234.
4. Kiyohara Y., Komada F., Iwakawa S., Hirai M., Fuwa T., Okumura K. Improvement in wound healing by epidermal growth factor (EGF) ointment: II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn. J. Pharmacobio-Dyn. 14:1991;47-52.
5. Kobayashi S., Takahashi C., Kuroda T., Sugenoya A., Iida F., Katoh K. Calcium regulating hormones and bone mineral content in patients after subtotal gastrectomy. Surg. Today. 24:1994;295-298.
6. Kohut A., Mahelova O., Mojzis J., Mirossay L. Effect of sialoadenectomy on stomach lesions induced by indomethacin and ethanol in relation to gastric vascular permeability, the gastrin level and HCl secretion in rats. Physiol. Res. 41:1992;381-386.
7. Konturek S.J., Brzozowski T., Drozdowicz D., Garlicki J., Majka J., Pytko-Polonczyk J. Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. Am. J. Med. 91(2A):1991;20S-29S.
8. Konturek S.J., Brzozowski T., Konturek P.K., Majka J., Dembinski A. Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress. Regul. Pept. 32:1991;203-215.
9. Kunizaki C., Sugiyama M., Tsuchiya S. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers in rats. Scand. J. Gastroenterol., Suppl. 162:1989;218-221.
10. Lambotte L., Saliez A., Triest S., Maiter D., Baranski A., Barker A., Li B. Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy. Hepatology. 25:1997;607-612.
11. Liao G.S., Li X.B., Zhang C.Y., Shu Y.Y., Tang S.X. Pharmacological actions of nerve growth factor-transferrin conjugate on the central nervous system. J. Nat. Toxins. 10:2001;291-297.
12. Matsuda H., Koyama H., Sato H., Sawada J., Itakura A., Tanaka A., Matsumoto M., Konno K., Ushio H., Matsuda K. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J. Exp. Med. 187:1998;297-306.
13. Mikus D., Sikiric P., Seiwerth S., Petricevic A., Aralica G., Druzijanic N., Rucman R., Petek M., Pigac B., Perovic D., Kolombo M., Kokic N., Mikus S., Duplancic B., Fattorini I., Turkovic B., Rotkvic I., Mise S., Prkacin I., Konjevoda P., Stmabuk N., Anic T. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns. 127:2001;817-827.
14. Olsen P.S., Poulsen S.S., Kirkegard P., Nexo E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology. 87:1984;103-108.
15. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 77:1979;761-767.
16. Sanders L.M., Hendren W.R. Protein Delivery. 1997;Plenum, New York.
17. Sandor Z., Vincze A., Szabo S. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J. 10:1996;171.
18. Sebecic B., Nikolic V., Sikiric P., Seiwerth S., Sosa T., Patrlj L., Grabarevic Z., Rucman R., Petek M., Konjevoda P., Jadrijevic S., Perovic D., Slaj M. Osteogenic effect of a gastric pentadecapeptide BPC 157, on the healing of segmental bone defect in rabbits. A comparison with bone marrow and autologous cortical bone implantation. Bone. 24:1999;195-202.
19. Selye H., Szabo S. Experimental model for production of perforating duodenal ulcers by cysteamine in the rat. Nature. 244:1973;458-459.
20. Sikiric P., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Turkovic B., Rotkvic I., Jagic V., Duvnjak M., Mise S. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci. 54:1994;PL63-PL68.
21. Sikiric P., Mikus D., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Peric J., Konjevoda P., Perovic D., Jurina L., Hanzevacki M., Separovic J., Gjurasin M., Jadrijevic S., Jelovac N., Miklic P., Buljat G., Marovic A. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies. Dig. Dis. Sci. 42:1997;1029-1037.
22. G-nitro-L- arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure. Eur. J. Pharmacol. 332:1997;23-33.
23. Sikiric P., Jadrijevic S., Seiwerth S., Sosa T., Deskovic S., Perovic D., Aralica G., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Ziger T., Rotkivc I., Mise S., Zoricic I., Sebecic B., Patrlj L., Kocman B., Sarlija M., Mikus D., Separovic J., Hanzevacki M., Gjurasin M., Miklic P. Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats. J. Physiol. (Paris). 93:1999;467-477.
24. Sikiric P., Seiwerth S., Deskovic S., Grabarevic Z., Marovic A., Rucman R., Petek M., Konjevoda P., Jadrijevic S., Sosa T., Perovic D., Aralica G., Turkovic B. New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin. Eur. J. Pharmacol. 364:1999;23-31.
25. Sikiric P., Separovic J., Anic T., Buljat G., Mikus D., Seiwerth S., Grabarevic Z., Stancic-Rokotov D., Pigac B., Hanzevacki M., Marovic A., Rucman R., Petek M., Zoricic I., Ziger T., Aralica G., Konjevoda P., Prkacin I., Gjurasin M., Miklic P., Artukovic B., Tisljar M., Bratulic M., Mise S., Rotkic I. The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. J. Physiol. (Paris). 93:1999;479-485.
26. Sikiric P., Seiwerth S., Aralica G., Perovic D., Staresinic M., Anic T., Gjurasin M., Prkacin I., Separovic J., Stancic-Rokotov D., Lovric-Bencic M., Mikus D., Turkovic B., Rotkvic I., Mise S., Rucman R., Petek M., Ziger T., Sebecic B., Ivasovic Z., Jagic V., Komericki L., Balen I., Boban-Blagaic A., Sjekavica I. Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat. J. Physiol. (Paris). 95:2001;295-301.
27. Sikiric P., Seiwerth S., Grabarevic Z., Balen I., Aralica G., Gjurasin M., Komericki L., Perovic D., Ziger T., Anic T., Prkacin I., Separovic J., Stancic-Rokotov D., Lovric-Bencic M., Mikus D., Staresinic M., Aralica G., DiBiaggio N., Simec Z., Turkovic B., Rotkvic I., Mise S., Rucman R., Petek M., Sebecic B., Ivasovic Z., Boban-Blagaic A., Sjekavica I. Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone. J. Physiol. (Paris). 95:2001;261-270.
28. Sikiric P., Seiwerth S., Mise S., Staresinic M., Bedekovic V., Zarkovic N., Borovic S., Gjurasin M., Boban-Blagaic A., Rucman R., Anic T. Corticosteroids-impairment healing and gastric pentadecapeptide BPC 157 creams in burned mice. Burns. 29:2003;323-334.
29. Stambuk N., Konjevoda P. Computational determination of biologically active motifs of the bone morphogenetic protein precursors. Period. Biol. 101:1999;363-368.
30. Staresinic M., Sebecic B., Jadrijevic S., Suknaic S., Perovic D., Aralica G., Zarkovic N., Borovic S., Srdjak M., Hajdarevic K., Kopljar M., Batelja L., Boban-Blagaic A., Turcic I., Anic T., Seiwerth S., Sikiric P. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J. Orthop. Res. 2003;. (in press).
31. Szabo S. Dopamine disorder in duodenal ulceration. Lancet. 2:1979;880-882.
32. Szabo S., Neumeyer J.L. Dopamine agonists and antagonists in duodenal ulcer disease. Kaiser C., Kebabian W. ACS Symposium Series. vol. 224:1983;175-196 American Chemical Society Publications, Washington.
33. Szabo S., Trier J.S., Brown A., Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology. 88:1985;228-236.
34. Tripp M.A., Tepperman B.L. Effect of nitric oxide on integrity, blood flow and cyclic GMP levels in the rat gastric mucosa: modulation by sialoadenectomy. Br. J. Pharmacol. 115:1995;344-348.
35. Urist M.R. The first three decades of bone morphogenetic protein. Osteologie. 4:1996;207-233.
36. Veljaca M., Chan K., Guglietta A. Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice. Gastroenterology. 108:1995;761.
37. Veljaca M., Krnic Z., Brajsa K., Mildner B., Pavic-Sladojev D., Seveljevic-Jaran D., Kolega M., Erceg D., Krznaric Z. The development of PL 14736 for treatment of inflammatory bowel disease. IUPHAR-GI Section Symposium, Honolulu, Hawaii, July 13-15, 2002. 2002;O-32.
38. Walsh J.H., Dockray G.J. Gut Peptides. Biochemistry and Physiology. 1994;Raven Press, New York.
39. Wu S.Q., Zhu W.Y., Yu J.R. Submaxillary gland epidermal growth factor accelerated healing of chronic gastric mucosal lesions in rats. Acta Physiol. Sin. 45:1993;575-580.